Examining daily stimulant medication use and sleep in adolescents with ADHD

Eur Child Adolesc Psychiatry. 2024 Mar;33(3):821-832. doi: 10.1007/s00787-023-02204-w. Epub 2023 Apr 12.

Abstract

Research has been inconclusive as to whether stimulant treatment causes or exacerbates sleep problems in adolescents with ADHD. This study examined sleep differences in adolescents with ADHD as a function of stimulant use. Participants were adolescents with ADHD (N = 159, ages 12-14). Parents reported on receipt of stimulant treatment (n = 92, 57.86%; n = 47 amphetamines, n = 45 methylphenidate). Adolescents wore actigraphs and completed daily diaries assessing sleep and daily use of stimulants for 2 weeks. Sleep parameters included daily-reported bedtime, sleep onset latency (SOL), sleep duration, daytime sleepiness, and difficulty waking the following morning; and actigraphy-measured sleep onset time, total time in bed, and sleep efficiency. We estimated between- and within-individual associations between stimulant medication use and sleep indices with all stimulants, after removing adolescents using sleep aids and weekend days, and as a function of stimulant type. Adolescent sleep did not differ between those receiving and not receiving stimulant treatment. Within individuals using stimulants, we largely observed no significant differences between medicated and unmedicated days, though findings were most often significant for school days only. Small effects were found indicating longer SOL, later sleep onset time, and more daytime sleepiness related to medication use. In contrast, there were slight improvements to sleep duration and sleep efficiency related to methylphenidate use, though methylphenidate was also associated with later sleep onset time and more daytime sleepiness. Given the inconsistent and small effects, findings suggest that stimulant medication may impact sleep, but does not appear to be a primary contributor to sleep problems in adolescents with ADHD.

Keywords: Attention-deficit/hyperactivity disorder; Methylphenidate; Psychopharmacology; Sleep.

MeSH terms

  • Adolescent
  • Attention Deficit Disorder with Hyperactivity* / complications
  • Attention Deficit Disorder with Hyperactivity* / drug therapy
  • Central Nervous System Stimulants* / therapeutic use
  • Disorders of Excessive Somnolence* / complications
  • Disorders of Excessive Somnolence* / drug therapy
  • Humans
  • Methylphenidate* / therapeutic use
  • Sleep
  • Sleep Wake Disorders* / drug therapy
  • Sleep Wake Disorders* / etiology

Substances

  • Methylphenidate
  • Central Nervous System Stimulants